Deutsche Bank AG lowered its position in Hamilton Lane Incorporated (NASDAQ:HLNE - Free Report) by 18.2% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 33,601 shares of the company's stock after selling 7,484 shares during the period. Deutsche Bank AG owned approximately 0.06% of Hamilton Lane worth $4,975,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other institutional investors have also added to or reduced their stakes in the company. Vanguard Group Inc. raised its holdings in shares of Hamilton Lane by 28.4% in the fourth quarter. Vanguard Group Inc. now owns 3,901,933 shares of the company's stock worth $577,681,000 after buying an additional 863,326 shares during the period. Invesco Ltd. increased its stake in Hamilton Lane by 25.3% in the fourth quarter. Invesco Ltd. now owns 1,923,253 shares of the company's stock worth $284,738,000 after purchasing an additional 388,019 shares during the period. Price T Rowe Associates Inc. MD lifted its position in shares of Hamilton Lane by 229.7% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 1,292,266 shares of the company's stock worth $191,321,000 after purchasing an additional 900,283 shares during the last quarter. Geode Capital Management LLC boosted its stake in shares of Hamilton Lane by 4.1% during the fourth quarter. Geode Capital Management LLC now owns 1,149,928 shares of the company's stock valued at $170,280,000 after purchasing an additional 44,865 shares during the period. Finally, T. Rowe Price Investment Management Inc. grew its holdings in shares of Hamilton Lane by 10.0% in the fourth quarter. T. Rowe Price Investment Management Inc. now owns 780,363 shares of the company's stock worth $115,533,000 after purchasing an additional 70,976 shares during the last quarter. Institutional investors own 97.40% of the company's stock.
Analysts Set New Price Targets
A number of brokerages recently weighed in on HLNE. Keefe, Bruyette & Woods lifted their price objective on shares of Hamilton Lane from $158.00 to $168.00 and gave the company a "market perform" rating in a report on Wednesday, February 5th. Morgan Stanley decreased their price target on shares of Hamilton Lane from $190.00 to $157.00 and set an "equal weight" rating for the company in a research note on Monday, April 14th. Oppenheimer cut Hamilton Lane from an "outperform" rating to a "market perform" rating in a research note on Thursday. JPMorgan Chase & Co. reduced their price objective on Hamilton Lane from $176.00 to $167.00 and set a "neutral" rating on the stock in a report on Tuesday, April 29th. Finally, Wells Fargo & Company lowered their target price on Hamilton Lane from $152.00 to $147.00 and set an "equal weight" rating for the company in a report on Tuesday, April 8th. One investment analyst has rated the stock with a sell rating and six have given a hold rating to the company's stock. According to data from MarketBeat.com, the company presently has an average rating of "Hold" and a consensus target price of $164.14.
Read Our Latest Research Report on Hamilton Lane
Hamilton Lane Stock Up 1.5%
Shares of NASDAQ HLNE opened at $172.74 on Monday. Hamilton Lane Incorporated has a 12-month low of $114.85 and a 12-month high of $203.72. The stock's fifty day simple moving average is $149.24 and its two-hundred day simple moving average is $159.59. The stock has a market capitalization of $9.58 billion, a PE ratio of 31.87 and a beta of 1.31. The company has a current ratio of 4.19, a quick ratio of 4.19 and a debt-to-equity ratio of 0.34.
Hamilton Lane Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Friday, April 4th. Investors of record on Friday, March 14th were given a dividend of $0.49 per share. This represents a $1.96 dividend on an annualized basis and a yield of 1.13%. The ex-dividend date was Friday, March 14th. Hamilton Lane's payout ratio is currently 36.16%.
Hamilton Lane Profile
(
Free Report)
Hamilton Lane Incorporated is a private equity firm specializing in early venture, emerging growth, turnaround, middle market, mature, mid-venture, bridge, buyout, distressed/vulture, loan, mezzanine in growth capital companies. It prefers to invest in energy, industrials, consumer discretionary, health care, real estate, information technology, utilities, and consumer services.
Further Reading
Want to see what other hedge funds are holding HLNE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hamilton Lane Incorporated (NASDAQ:HLNE - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Hamilton Lane, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hamilton Lane wasn't on the list.
While Hamilton Lane currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.